Back to results
US 8,076,354 B2Granted
Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
AssigneeAstex Therapeutics Limited
InventorsGordon Saxty, Valerio Berdini, Christopher William Murray, Charlotte Mary Griffiths-Jones, Emma Vickerstaffe, Gilbert Ebai Besong, Maria Grazia Carr
Life of this patent
Estimating the term…
Abstract
The invention relates to new bicyclic heterocyclic derivative compounds of formula (I): wherein R1, A, X1, X2, X3, X4, X5 and R2 are as defined herein, to pharmaceutical compositions comprising said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
Claims13
A compound of formula (I):
- wherein
- represents a single or double bond, such that at least one bond within the 5 membered ring system is a double bond;
- Ring A may be optionally substituted by 1,2 or 3 Ra groups;
- R4 and R5 independently represent hydrogen, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-8 cycloalkyl, C3-8 cycloalkenyl, C1-6 alkanol, haloC1-6 alkyl, —(CH2)n—NRxRy, —(CH2)s—COORz, —(CH2)n—O—(CH2)m—OH, —(CH2)n-aryl, —(CH2)n—O-aryl, —(CH2)n-heterocyclyl or —(CH2)n—O-heterocyclyl wherein said C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-8 cycloalkyl, C3-8 cycloalkenyl, aryl and heterocyclyl groups may be optionally substituted by 1, 2 or 3 Ra groups;
- Rx, Ry and Rz independently represent hydrogen, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkanol, —COOC1-6 alkyl, hydroxy, C1-6 alkoxy, haloC1-6 alkyl, —CO—(CH2)n—C1-6 alkoxy, C1-6 alkylamino, C3-8 cycloalkyl or C3-8 cycloalkenyl;
- R2 represents a —CONR7R8 or —CORx group;
- R7 and R8 independently represent hydrogen, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-8 cycloalkyl, C3-8 cycloalkenyl, aryl, heterocyclyl or R7 and R8 together with the nitrogen atom to which they are attached may form a nitrogen containing heterocyclyl ring, wherein said C1-6 alkyl, aryl and heterocyclyl may be optionally substituted by 1, 2 or 3 Rb groups;
- Ra represents halogen, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-8 cycloalkyl, C3-8 cycloalkenyl, —ORx, —O—(CH2)n—ORx, haloC1-6 alkyl, haloC1-6 alkoxy, C1-6 alkanol, ═O, ═S, nitro, Si(Rx)4, —(CH2)s—CN, —S—Rx, —SO—Rx, —SO2—Rx, —CORx, —(CRxRy)s—COORz, —(CH2)s—, CONRxRy, —(CH2)s—NRxRy, —(CH2)s—NRxCORy, —(CH2)s—NRxSO2—Ry, —(CH2)s—NH—SO2—NRxRy, —OCONRxRy, —(CH2)s—NRxCO2Ry, —O—(CH2)s—CRxRy—(CH2)t—ORz or —(CH2)s—SO2NRxRy groups;
- Rb represents an Ra group or a —Y-carbocyclic or —Z-heterocyclyl group wherein said carbocyclic and heterocyclyl groups may be optionally substituted by 1, 2 or 3 Ra groups;
- Y and Z independently represent a bond, —CO—(CH2)s—, —COO—, —(CH2)n—, —NRx—(CH2)s—, —(CH2)s—NRx—, —CONRx—, —NRxCO—, —SO2NRx—, —NRxSO2—, —NRxCONRy—, —NRxCSNRy—, —O—(CH2)s—, —(CH2)s—O—, —S—, —SO— or —(CH2)s—SO2—;
- m and n independently represent an integer from 1-4;
- s and t independently represent an integer from 0-4;
- or a pharmaceutically acceptable salt thereof.
10 more elements
Dependencies are inferred from the claim text.